EC HEALTHCARE (02138) announced its interim results for the six months ended September 30, 2025. The company reported total revenue of approximately HK$1.931 billion, representing a year-on-year decrease of 6.4%. Net loss attributable to equity shareholders amounted to HK$10.312 million, compared to a profit in the same period last year. The loss per share was HK$0.009.

The decline in profitability was primarily attributed to reduced revenue and sales volume, which lowered operating leverage across major business segments. Additionally, a shift in service mix toward lower-margin categories and the absence of income from divested medical assets—which contributed to profits in the prior-year period—further impacted the group's earnings.